Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40000685
Localisation
Denmark
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
02/05/2024
Statut
Classification
1.5°C
Année cible
2029
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target: H. Lundbeck A/S commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: H. Lundbeck A/S commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2029 from a 2019 base year.* H. Lundbeck A/S commits to reduce absolute scope 3 GHG emissions from purchased goods and services, upstream transportation and distribution and business travel 25% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: H. Lundbeck A/S commits to reduce absolute scope 1, 2 and 3 GHG emissions 90% by 2050 from a 2019 base year.* *The target boundary includes land-related emissions and removals from bioenergy feedstocks.
Statut
Targets setAnnée cible
2050
Statut
BA1.5 memberDate d'engagement
01/11/2019
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
DK0061804770
LEI
5493006R4KC2OI5D3470
Source : Science Based Targets initiative | Données publiques